Filing Details
- Accession Number:
- 0000950170-25-049800
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-04-02 20:08:27
- Reporting Period:
- 2025-04-01
- Filing Date:
- 2025-04-02
- Accepted Time:
- 2025-04-02 20:08:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1088856 | Corcept Therapeutics Inc | CORT | Pharmaceutical Preparations (2834) | 770487658 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1879013 | William Guyer | C/O Corcept Therapeutics Incorporated 101 Redwood Shores Parkway Redwood City CA 94065 | Chief Development Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-04-01 | 678 | $21.65 | 6,165 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-04-01 | 678 | $114.51 | 5,487 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock option (right to buy) | Disposition | 2025-04-01 | 678 | $0.00 | 678 | $21.65 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 449,322 | 2031-09-01 | No | 4 | M | Direct |
Footnotes
- The transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on November 27, 2024 in effect at the time of this transaction.
- Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $114.29 to $114.71 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- Fully exercisable.
Billionaire Hedge Funds
